Sankar D Navaneethan

11PUBLICATIONS
44CO-AUTHORS
Predictive and prognostic markersExercise physiologyCardiology (incl. cardiovascular diseases)Epidemiological modellingMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 23, 2026
Pentoxifylline for chronic kidney disease in people with diabetes: a meta-analysis of randomized trials.

|Sep 29, 2026
Physical Performance and Risk of Heart Failure, Kidney Failure, and Mortality in CKD: Findings from the CRIC Study.

|Sep 02, 2026
Executive Summary of the ASN Kidney Health Guidance on the Cardiovascular‑Kidney‑Metabolic Syndrome.

|Sep 02, 2026
ASN Kidney Health Guidance on the Cardiovascular-Kidney-Metabolic Syndrome.

|Jun 05, 2026
Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.

|Mar 30, 2026
Current Insights and Future Directions on the Role of GLP-1 Receptor Agonists in Chronic Kidney Disease.

Kavya Rajan, Arjun Krishen Jutley, Michael W Holliday

Pageof 2

Frequent Collaborators

3 joint publications

Amy K Mottl

2 joint publications

Michael W Holliday

2 joint publications

Rajiv Agarwal

2 joint publications

Brian S Rifkin